Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bongarzoni, A."'
Autor:
Velia Bongarzoni, Dimitar G. Efremov, Robin Foà, Giovanni Del Poeta, Roberta Murru, Stefania Ciolli, Maria Rosa Lanza Cariccio, Francesca Romana Mauro, Maria Ilaria Del Principe, Riccardo Boncompagni, Maria Cantonetti, Agostino Cortelezzi, Giovanni D'Arena, Idanna Innocenti, Francesco Ghio, Patrizia Mondello, Simona Sica, Vincenzo Pitini, Barbara Vannata, Nicola Piccirillo, Giulia Cervetti, Francesco Autore, Gianluigi Reda, Paola Anticoli Borza, Luca Laurenti, Alessandro Gozzetti
Publikováno v:
Leukemia Research. 39:1066-1070
The front-line therapy for CLL young and fit patients is chemo-immunotherapy with fludarabine-cyclophosphamide-rituximab (FCR). FCR regimen results in a significant myelosuppression and high rates of early and late infections especially in elderly pa
Autor:
Enrico Orciuolo, Emilio Iannitto, Pier Luigi Zinzani, Monica Balzarotti, Benedetta Puccini, Caterina Patti, Luigi Rigacci, Andrea Piccin, Gianluca Gaidano, Marco De Gobbi, Velia Bongarzoni, Delia Rota-Scalabrini, Sergio Storti, Roberto Freilone, Alberto Bosi, Francesco Zaja, Anna Marina Liberati, Sergio Cortelazzo, Alfonso Maria D'Arco, Andrea Carpaneto
Bendamustine is an alkylating agent with a nitrogen mustard group and a purine-like benzimidazole group. The aim of this study was to collect all the Italian experiences with this drug in order to evaluate the results in term of response to therapy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee57492dc9e0745b5f1fc68b3c3dfb17
http://hdl.handle.net/11585/120188
http://hdl.handle.net/11585/120188
Autor:
Daniele Derudas, Donatella Vincelli, Velia Bongarzoni, Sergio Storti, Catello Califano, Vincenzo Ludovico Fraticelli, Pellegrino Musto, Emanuela Madonna, Francesca Patriarca, Giuseppe Mele, Luca Baldini, Renato Zambello, Stelvio Ballanti, Anna Baraldi, Alberto Mussetti, Alessandro Andriani, Andrea Nozza, Alberto Fragasso, Giovanna Mansueto, Antonietta Falcone
Publikováno v:
Leukemialymphoma. 56(5)
Bendamustine is an old bi-functional alkylating agent which, thanks to its extended efficacy and good tolerability, is living a second youth with growing use in several lympho-proliferative maligna...
Autor:
Emilio, Iannitto, Fortunato, Morabito, Salvatrice, Mancuso, Massimo, Gentile, Antonella, Montanini, Accursio, Augello, Velia, Bongarzoni, Alfonso, D'Arco, Nicola, Di Renzo, Rita, Fazzi, Giovanni, Franco, Roberto, Marasca, Antonino, Mulè, Maurizio, Musso, Pellegrino, Musto, Elsa, Pennese, Andrea, Piccin, Delia, Rota-Scalabrini, Giuseppe, Visani, Luigi, Rigacci
To retrospectively assess the efficacy of bendamustine alone and with rituximab (R-B), 109 patients with relapsed chronic lymphocytic leukaemia (CLL) were enrolled in 24 Italian centres. The median age was 66 years (range 39-85). Forty-three percent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9b5cf7d7c5dfa70f1349562d7a847d05
http://hdl.handle.net/10447/75023
http://hdl.handle.net/10447/75023